iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Reaches New 1-Year High – What’s Next?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) shares hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $87.07 and last traded at $87.07, with a volume of 75284 shares trading hands. The stock had previously closed at $86.03.

iShares U.S. Pharmaceuticals ETF Stock Up 1.3%

The firm has a market capitalization of $971.28 million, a price-to-earnings ratio of 17.75 and a beta of 0.54. The company has a fifty day moving average price of $83.49 and a two-hundred day moving average price of $75.11.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in IHE. National Bank of Canada FI increased its stake in shares of iShares U.S. Pharmaceuticals ETF by 42.7% during the 3rd quarter. National Bank of Canada FI now owns 585 shares of the company’s stock valued at $42,000 after acquiring an additional 175 shares during the last quarter. Wealthcare Advisory Partners LLC increased its position in shares of iShares U.S. Pharmaceuticals ETF by 4.3% during the second quarter. Wealthcare Advisory Partners LLC now owns 4,898 shares of the company’s stock worth $321,000 after acquiring an additional 201 shares during the last quarter. Arkansas Financial Group Inc. grew its position in shares of iShares U.S. Pharmaceuticals ETF by 3.2% during the third quarter. Arkansas Financial Group Inc. now owns 7,415 shares of the company’s stock worth $561,000 after buying an additional 230 shares in the last quarter. Envestnet Asset Management Inc. lifted its position in shares of iShares U.S. Pharmaceuticals ETF by 2.8% during the second quarter. Envestnet Asset Management Inc. now owns 8,633 shares of the company’s stock worth $566,000 after purchasing an additional 238 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its position in shares of iShares U.S. Pharmaceuticals ETF by 6.0% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 4,207 shares of the company’s stock worth $316,000 after acquiring an additional 240 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.